Is MGMT promoter methylation to be considered in the decision making for recurrent surgery in glioblastoma patients?

Surgical management for recurrent glioblastoma appears to be a safe procedure which results in longer OS in comparison to non-surgical management. GTR may be of particular benefit to patients with unmethylated MGMT promoter rGB.